Medscape Medical NewsAll articles

TMINI Miniature Robotic System

THINK Surgical, Inc. • Neurology • 01/06/2025

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The THINK Surgical TMINI Miniature Robotic System is designed as a stereotaxic instrument to assist surgeons in achieving precise implant component placement during total knee replacement (TKA) surgeries. It operates by utilizing preoperative CT scans for surgical planning and guiding a robotically controlled hand-held tool within software-defined spatial boundaries, enhancing surgical accuracy and consistency.

Summary

The THINK Surgical, Inc.'s TMINI Miniature Robotic System, a Class II stereotaxic instrument, underwent a regulatory review and was determined to be substantially equivalent for its intended indications for use. This regulatory milestone permits the system's marketing, provided the manufacturer adheres to general controls, including annual registration, device listing, good manufacturing practice, and accurate labeling, alongside other obligations like the Quality System regulation and Unique Device Identification System rule. The TMINI system is specifically indicated for total knee replacement (TKA) surgery, where it functions by providing surgeons with software-defined spatial boundaries and reference information for precise knee implant component placement. Its methodology involves leveraging preoperative CT scans for detailed surgical planning and then guiding a robotically controlled hand-held tool. Recent enhancements include updates to the TPLAN Planning Station's algorithms for segmentation, improved DICOM data handling, implant display, and cybersecurity, plus a new web-based application for remote surgical plan review. Performance testing and risk analysis have confirmed that these modifications do not alter the system's core function, indications, or introduce new safety or effectiveness concerns.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

TMINI Miniature Robotic SystemTotal Knee Replacement (TKA)Stereotaxic instrumentSurgical planningRobotic assistanceCT scansImplant placementRegulatory approvalSubstantial equivalenceCybersecurity

Device Metadata

Submission Number
K243481
Company
THINK Surgical, Inc.
Panel
Neurology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. How do the recent segmentation algorithm improvements specifically enhance the accuracy and efficiency of surgical planning compared to previous iterations?; What is the long-term clinical data on patient outcomes, revision rates, and functional recovery when TKA is performed using the TMINI system compared to conventional or other robotic methods?; What are the specific cybersecurity measures implemented to protect patient DICOM data and surgical plans, especially with the addition of the web-based remote review application?; Can the system adapt to anatomical variations or intraoperative changes not captured in the preoperative CT scans, and what are the surgeon's options in such scenarios?; What is the learning curve for surgeons utilizing the TMINI system, and what training or support is provided to ensure optimal use and minimize complications?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score30/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, labeling)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(remote)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
TMINI Miniature Robotic System - THINK Surgical, Inc. | ESL FDA AI Device Intelligence